TP53 and breast carcinoma: Molinari and coworkers [44] found that estrogen treatment of breast cancer cell lines modified the intracellular distribution and functional activity of p53, indicating estradiol-induced inactivation of p53 might contribute to carcinogenesis of estrogen-dependent tumors.